ANI director Thoma sells 1,000 shares at $71.53

ANI Pharmaceuticals director Jeanne Thoma sold 1,000 ANIP shares under a pre-arranged Rule 10b5-1 trading plan and continues to hold 26,762 shares.

Rhea-AI Filing Summary

ANI PHARMACEUTICALS INC (ANIP) director Jeanne Thoma reported selling 1,000 shares of common stock on September 11, 2026 at $71.53 per share in an open-market or private transaction. After this sale, she directly holds 26,762 shares. The sale was effected under a Rule 10b5-1 trading plan adopted on June 12, 2026.

Insider Trade Summary 10b5-1

Net Seller: 1,000 shares

Net Sell 1 txn

Insider Thoma Jeanne

Role Director

Sold 1,000 shs ($72K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,000	$71.53	$72K

Holdings After Transaction: Common Stock — 26,762 shares (Direct)

Footnotes (1)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026.

Key Figures

Shares sold: 1,000 shares Sale price per share: $71.53 per share Shares owned after transaction: 26,762 shares +2 more

5 metrics

Shares sold 1,000 shares Common Stock sale reported for September 11, 2026

Sale price per share $71.53 per share Price for the 1,000 ANIP shares sold on September 11, 2026

Shares owned after transaction 26,762 shares Direct holdings of Jeanne Thoma following the reported sale

Net shares sold 1,000 shares Net sell direction across all transactions in this Form 4

Rule 10b5-1 plan adoption date June 12, 2026 Date Jeanne Thoma adopted the trading plan covering these sales

Key Terms

Rule 10b5-1 trading plan, Common Stock, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The sales were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Common Stock financial

"security title is listed as Common Stock for the transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open market or private transaction financial

"described as a Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ANIP director Jeanne Thoma report on this Form 4?

Jeanne Thoma reported a sale of 1,000 shares of ANI Pharmaceuticals common stock on September 11, 2026 in an open-market or private transaction at $71.53 per share.

How many ANIP shares does Jeanne Thoma hold after this reported sale?

After the reported sale, Jeanne Thoma directly owns 26,762 shares of ANI Pharmaceuticals common stock, as stated in the filing.

Was Jeanne Thoma’s ANIP stock sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan that Jeanne Thoma adopted on June 12, 2026.

What was the price per share in Jeanne Thoma’s ANIP stock sale?

The reported sale of ANI Pharmaceuticals common stock by Jeanne Thoma was executed at a price of $71.53 per share.

What is the net share change from Jeanne Thoma’s reported ANIP transaction?

The net change is a disposition of 1,000 shares, as the filing reports 1,000 shares sold and no purchases or other acquisitions in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 08:57 PM Accepted by SEC EDGAR 09/14/2026 - 08:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thoma Jeanne

(Last) (First) (Middle)

C/O ANI PHARMACEUTICALS, INC.

104 CARNEGIE CENTER, SUITE 300

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ANI PHARMACEUTICALS INC [ ANIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		S(1)		1,000	D	$71.53	26,762	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026.

Remarks:

	/s/ Jeanne A. Thoma, by attorney-in-fact Meredith W. Cook	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)